Alvine Pharmaceuticals, Inc. Announces Equity Investment by Abbott Biotech Ventures Inc.
5/26/2010 8:28:59 AM
SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals, Inc., a privately held clinical stage biopharmaceutical company focused on developing and commercializing therapeutics for autoimmune/inflammatory diseases, today announced that Abbott Biotech Ventures Inc., has joined Alvine’s current investors: Interwest Partners, Panorama Capital, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures in the company’s Series A Extension financing. The terms of the investment were not disclosed.
comments powered by